Fig. 4. PLS-DA score plot of plasma samples after three weeks treatment of PP242 at a dose of 60 mg.kg-1.day-1. (A) Metabolomics (ES⁺; R² = 0.43, Q² = 0.1), (B) metabolomics (ES⁻; R² = 0.43, Q² = 0.21), (C) Lipidomics (ES⁺; R² = 0.61, Q² = 0.20), and Lipidomics (ES⁻; R² = 0.51, Q² = 0.17).